The National Institute of Health (NIH) has implemented a ban on sponsored foreign trips for doctors and hospital staff by private companies, signaling a significant shift in policy. This directive, communicated via a letter to federal government-run hospitals, underscores the NIH’s stance on ensuring transparency and independence in medical practices.
The letter specifies that all requests for Ex-Pakistan leave must be accompanied by an affidavit from the concerned officers affirming that their foreign visits are not sponsored by private companies or donors, and are not for the purpose of attending conferences or seminars. This measure aims to prevent undue influence from pharmaceutical companies and other external entities on medical professionals.
Also Read: Gilgit-Baltistan to Lower Retirement Age for Doctors
In a related development, the Drug Regulatory Authority of Pakistan (DRAP) has introduced a new code of conduct aimed at regulating the relationship between pharmaceutical companies and doctors. This move comes after receiving approval from the federal government.
Under the new regulations, pharmaceutical companies are barred from covering travel expenses for family members or other individuals accompanying doctors on sponsored trips. Additionally, doctors will only be eligible for reimbursement of foreign travel expenses if they obtain a No Objection Certificate (NOC) from their respective institutions, further ensuring accountability and transparency in medical engagements abroad.
